Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.
about
West Nile virus: review of the literatureWest Nile Virus: biology, transmission, and human infectionVaccines in development against West Nile virusApproved Antiviral Drugs over the Past 50 YearsFast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effectsImmunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal deliveryAssurance of neuroattenuation of a live vaccine against West Nile virus: a comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine.Globalization, land use, and the invasion of West Nile virus.Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus.Regulation of cell survival and death during Flavivirus infections.Effect of serum heat-inactivation and dilution on detection of anti-WNV antibodies in mice by West Nile virus E-protein microsphere immunoassay.Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.Meteorological conditions associated with increased incidence of West Nile virus disease in the United States, 2004-2012.Impact of viral attachment factor expression on antibody-mediated neutralization of flaviviruses.A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibodyWest Nile virus: A re-emerging pathogen revisited.A review of vaccine approaches for West Nile virus.Exploring the spatio-temporal dynamics of reservoir hosts, vectors, and human hosts of West Nile virus: a review of the recent literatureUsutu virus.B cell response and mechanisms of antibody protection to West Nile virus.Ensemble forecast of human West Nile virus cases and mosquito infection rates.A review of the epidemiological and clinical aspects of West Nile virus.West Nile virus infection and immunity.West nile virus infections in children.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.Mapping the serological prevalence rate of West Nile fever in equids, Tunisia.Fatal transplant-associated west nile virus encephalitis and public health investigation-california, 2010.West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses.Safety and immunogenicity of a chimeric vaccine for West Nile virus in aged subjects.West nile virus.
P2860
Q26827766-CCE34E95-9634-4192-83E8-910E216312B5Q26865618-BEC05BE2-F37D-4447-9857-7323B0E81D65Q26999702-EFCFF868-F3EE-437A-B5D3-03917CB1C42BQ27755387-30CA4F84-2C94-440B-9133-DB39CD4FAAEFQ27928013-DA329A23-4DE4-4EA2-9CB3-0EA8234A6FD1Q33584872-9163B5C9-AEF4-4569-B0DA-EE4D9EA2EE82Q33909344-1C06B432-F83A-4826-A38C-6812E55BE82BQ34055080-7EFF2DEF-7EBB-40D2-86C7-A5FF9F89B2E6Q34208783-53C5E9AE-46A0-416A-99C8-2E101F06B4B8Q34424352-C446AF4A-507E-4E37-B7F7-7E225DCCE984Q34438501-A7FF59B6-9EA8-437E-8E55-7344A0922831Q35531167-73491733-DD5E-49F2-B83C-67BCB8ED253BQ35590668-08ECEFF7-DDD0-48C6-8BF8-5FB87104AD02Q36697323-8368BC8A-FC13-4212-B8A5-34ACAD37CB7DQ37012203-B10F6F60-D81D-46B3-9F82-65B76EE2C78BQ37123147-B2EF8A5B-FF39-4F70-AA07-81A7A1F3D189Q37195527-877538F1-2963-4F00-A85E-946DD35B8640Q37236968-0414F915-EC07-4C4C-9C38-288150349802Q37393930-30FF9028-0299-4A17-8820-A35C1E712DD0Q37630301-F39E08AE-5702-4B50-926C-F8720B70BBBEQ37673123-F8E98820-C19D-4846-9257-A5BF14A76997Q37676320-8F28A856-690D-4549-A067-469A7957F007Q37708659-6A8F3F27-E7E0-4ABF-ADFD-27D59659D731Q38074266-7E179156-27EA-4FBA-9D55-74B5666DDF40Q38190430-DE7AE71E-1994-40C3-836B-A9B21B8B7DA7Q38866173-43355F47-A3CB-4E97-8785-866F0DBC3C25Q38893278-F5F50A44-7468-4B88-8ED4-0E54C6108F1BQ40242280-9256D6DB-E5AA-4A35-A1A3-F8BD865C4581Q40269573-F2143CB2-FC73-45BF-8786-9AB3109E9D24Q40324111-4368445B-91DC-42A9-8E35-CB085DB04270Q51860606-CDFCD266-5E69-433D-AA37-2C2A4F13B640
P2860
Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vaccines and immunotherapeutic ...... fections with West Nile virus.
@en
Vaccines and immunotherapeutic ...... fections with West Nile virus.
@nl
type
label
Vaccines and immunotherapeutic ...... fections with West Nile virus.
@en
Vaccines and immunotherapeutic ...... fections with West Nile virus.
@nl
prefLabel
Vaccines and immunotherapeutic ...... fections with West Nile virus.
@en
Vaccines and immunotherapeutic ...... fections with West Nile virus.
@nl
P2860
P356
P1433
P1476
Vaccines and immunotherapeutic ...... fections with West Nile virus.
@en
P2860
P304
P356
10.2217/IMT.10.93
P577
2011-02-01T00:00:00Z